These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29200871)
1. The clinical significance of CXCL5 in non-small cell lung cancer. Wu K; Yu S; Liu Q; Bai X; Zheng X; Wu K Onco Targets Ther; 2017; 10():5561-5573. PubMed ID: 29200871 [TBL] [Abstract][Full Text] [Related]
2. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients. Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215 [TBL] [Abstract][Full Text] [Related]
3. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219 [TBL] [Abstract][Full Text] [Related]
4. Serum CXCL5 level is associated with tumor progression in penile cancer. Mo M; Li Y; Hu X Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33458757 [TBL] [Abstract][Full Text] [Related]
5. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Lim JB; Chung HW Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618 [TBL] [Abstract][Full Text] [Related]
6. CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells. Wang L; Shi L; Gu J; Zhan C; Xi J; Ding J; Ge D J Physiol Biochem; 2018 May; 74(2):313-324. PubMed ID: 29526026 [TBL] [Abstract][Full Text] [Related]
7. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877 [TBL] [Abstract][Full Text] [Related]
8. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling. Han N; Yuan X; Wu H; Xu H; Chu Q; Guo M; Yu S; Chen Y; Wu K Oncotarget; 2015 Mar; 6(8):5877-88. PubMed ID: 25788272 [TBL] [Abstract][Full Text] [Related]
9. CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer. Yu S; Yi M; Xu L; Qin S; Li A; Wu K Front Oncol; 2019; 9():1515. PubMed ID: 31998654 [No Abstract] [Full Text] [Related]
10. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration. Zhang R; Liu Q; Peng J; Wang M; Li T; Liu J; Cui M; Zhang X; Gao X; Liao Q; Zhao Y J Cancer; 2020; 11(9):2371-2381. PubMed ID: 32201508 [No Abstract] [Full Text] [Related]
11. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Zhang W; Wang H; Sun M; Deng X; Wu X; Ma Y; Li M; Shuoa SM; You Q; Miao L Cancer Commun (Lond); 2020 Mar; 40(2-3):69-80. PubMed ID: 32237072 [TBL] [Abstract][Full Text] [Related]
12. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling. Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837 [TBL] [Abstract][Full Text] [Related]
13. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Gong J; Zhang H; He L; Wang L; Wang J Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810 [TBL] [Abstract][Full Text] [Related]
14. CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer. Wu B; Wang J; Wang X; Zhu M; Chen F; Shen Y; Zhong Z Oncol Lett; 2020 Nov; 20(5):257. PubMed ID: 32994820 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685 [TBL] [Abstract][Full Text] [Related]
16. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791 [TBL] [Abstract][Full Text] [Related]
17. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer. Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367 [TBL] [Abstract][Full Text] [Related]
18. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858 [TBL] [Abstract][Full Text] [Related]
19. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]